1- Yadoollahi Farsi J, Kalanhaei Z. Technology exploitation mechanisms in biotechnology. Roshd-e-Fanavari Journal of Science & Technology Parks and Incubators. 2012; 8(3):62-70. [Persian]
2- Hamidi Motlagh R., Isaai M., Babaee A. embeddedness of state-pioneer entrepreneurs and technological change; the case of biopharmecutal catch-up in Iran. Journal of Science and Technology Policy, 2016; 9(4): 1-18. [Persian]
3- Saber A, Elahi S, Majidpour M., Shayan A, Sahebkar khorasani, S. Investigating the technological catch-up efforts in biopharmaceutical firms of Iran. Journal of Science and Technology Policy, 2018; 11(4): 49-63. [Persian]
4- Tabatabaeian S, Tahoori H, Taghva M, Taghavi Fard S. Analysis of innovation ecosystem of Iranian biopharmaceuticals. Journal of Technology Development Management, 2018; 6(1): 9-45. [Persian]
5- Taslimi M, Naghavi M., Mokhtarzadeh N, Babaei A. The role of intermediary institutions in the emergence of biopharma industry in Iran. Journal of Science and Technology Policy, 2018; 11(3): 29-44. [Persian]
6- Afshari Mofrad M, Salim A. Iranian firms in biopharmaceutical value chain: Where to go now?. Journal of Science and Technology Policy Management. 2019 Jun 12; 11(1): 49-63.
7- Chesbrough H, Vanhaverbeke W, West J, editors. Open innovation: Researching a new paradigm. Oxford University Press on Demand; 2006 Aug 10.
8- Enkel E, Gassmann O, Chesbrough H. Open R&D and open innovation: Exploring the phenomenon. R&D Management. 2009 Sep;39(4):311-6.
9- Goodarzi M, Goodarzi M. Review of Commercialization process of biopharmaceuticals: Lessons for Iran’s drug industry. Rahyaft, 2014; 24(1): 35-53. [Persian]
10- Radfar R, Pilevari N, Ghazinoory, SS, Shakeri, R. Study of firm-level strategic alliances drivers; case study Pharmaceutical industry. Management Researches, 2015; 8(27): 45-70. [Persian]
11- Bogers M, Chesbrough H, Moedas C. Open innovation: Research, practices, and policies. California management review. 2018 Feb;60(2):5-16.
12- Chesbrough H. Managing open innovation. Research-Technology Management. 2004 Jan 1;47(1):23-6.
13- Khaleghi, M., Elyasi, M. The new approach of open innovation: Basic concepts, literature and horizons ahead. Journal of Technology Development, 2016; 14(28): 87-100. [Persian]
14- Siadati H, Mofrad MA. Policies for promoting open innovation. Journal of Science and Technology Policy. 2019;11(2):379-393. [Persian]
15- Marques JP. Closed versus open innovation: Evolution or combination?. International Journal of Business and Management. 2014 Feb 1;9(3):196.
16- Chesbrough HW. Open innovation: The new imperative for creating and profiting from technology. Harvard Business Press; 2003.
17- Safdari Ranjbar M, Manteghi M, Tavakoli G. Open innovation: A comprehensive view on concepts, approaches, trends and key success factors. Roshd-e-Fanavari Journal of Science & Technology Parks and Incubators. 2014;10(40):45-65. [Persian]
18- Pajohesh Jahromi, A. Taxonomy of Open Innovation. Rahyaft, 2019;29(73):1-12. [Persian]
19- Chiesa V, Manzini R. Organizing for technological collaborations: a managerial perspective. R&D Management. 1998 Jul;28(3):199-212.
20- Majidpour M, Mojiri F. The evolution of the concepts and policies of international technology transfer. Journal of Science and Technology Policy, 2019;11(2):425-437. [Persian]
21- Harwood, R. The Open Innovation Methods Matrix. 100 open. 2016. accessed through https://www.100open.com/the-open-innovation-methods-matrix-part-1/
22- Van der Zee F, Rehfeld D, Hamza C. Open innovation in industry, including 3D printing. Study for the European Parliament. 2015.
23- Schuhmacher A, Germann PG, Trill H, Gassmann O. Models for open innovation in the pharmaceutical industry. Drug Discovery Today. 2013 Dec 1;18(23-24):1133-7.
24- Michelino F, Lamberti E, Cammarano A, Caputo M. Measuring open innovation in the Bio‐Pharmaceutical industry. Creativity and Innovation Management. 2015 Mar;24(1):4-28.
25- Raja, B. H. Open innovation in pharmaceutical industry: A case study of Eli Lilly. M.Sc. Thesis in KTH University, Sweden. 2015.
26- Bianchi M, Cavaliere A, Chiaroni D, Frattini F, Chiesa V. Organisational modes for open innovation in the bio-pharmaceutical industry: An exploratory analysis. Technovation. 2011 Jan 1;31(1):22-33.
27- Chiaroni D, Chiesa V, Frattini F. Investigating the adoption of open innovation in the bio‐pharmaceutical industry. European Journal of Innovation Management. 2009 Jul 31.
28- Munos B. Lessons from 60 years of pharmaceutical innovation. Nature Reviews Drug Discovery. 2009 Dec;8(12):959-68.
29- Sabatier V, Mangematin V, Rousselle T. Orchestrating networks in the biopharmaceutical industry: Small hub firms can do it. Production Planning and Control. 2010 Mar 1;21(2):218-28.
30- Mazzola E, Bruccoleri M, Perrone G. Open innovation and firms performance: State of the art and empirical evidences from the bio-pharmaceutical industry. International Journal of Technology Management. 2016;70(2-3):109-34.
31- Hu MC, Hung SC. Taiwan's pharmaceuticals: A failure of the sectoral system of innovation?. Technological Forecasting and Social Change. 2014 Oct 1;88:162-76.
32- Xia T, Roper S. From capability to connectivity—Absorptive capacity and exploratory alliances in biopharmaceutical firms: A US–Europe comparison. Technovation. 2008 Nov 1;28(11):776-85.
33- Hu Y, McNamara P, McLoughlin D. Outbound open innovation in bio-pharmaceutical out-licensing. Technovation. 2015 Jan 1;35:46-58.
34- Östlund U, Kidd L, Wengström Y, Rowa-Dewar N. Combining qualitative and quantitative research within mixed method research designs: a methodological review. International journal of nursing studies. 2011 Mar 1;48(3):369-83.
35- Creswell JW, Clark VLP, Gutmann ML, Hanson WE. Advanced Mixed methods Research Designs. In Handbook of mixed methods in social & behavioral research. Sage.
36- Rush H, Bessant J, Hobday M, Hanrahan E, Medeiros MZ. The evolution and use of a policy and research tool: assessing the technological capabilities of firms. Technology Analysis & Strategic Management. 2014 Mar 16;26(3):353-65.
37- Kale D, Little S. From imitation to innovation: The evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry. Technology Analysis & Strategic Management. 2007 Sep 1;19(5):589-609.